• REUTERS

  • SHARE

Daiichi Sankyo Co. is in discussions to provide supplies of a potential coronavirus vaccine now being developed by AstraZeneca PLC and the University of Oxford for use in Japan.

The discussion follows a flurry of supply deals signed by the British drugmaker for its experimental COVID-19 vaccine as it ramps up efforts for wider trials of the potential treatment.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)